glp-1 drug brands List of approved and pending medications Decoding GLP-1 Weight Loss Medications

Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a groundbreaking treatment for Type 2 diabetes mellitus (T2DM) and obesity

The GLP-1 market is projected

GLP-1 patches are experimental microneedle and transdermal systems being studied as alternatives to injections for type 2 diabetes and weight loss

Comprehensive searches were conducted in the Cochrane Database, PubMed, MEDLINE, ClinicalTrials.gov, and EMBASE for publications from January 2010 to June 2022, with an additional search extended through June 2025 to capture newly published studies

- & : Experience targeted metabolic support with GlucoVantage, Chromium Picolinate, and plant-based fibers

Preliminary evidence suggests women who took GLP-1s before conceiving actually had healthier pregnancies compared to women not on GLP-1s but more research is needed.